Table 1.
Patient number | Oxalate (mg/day) | Citrate (mg/day) | Volume (L/day) | |
---|---|---|---|---|
RYGB and 24-h urine (∼12 months F/U) | ||||
Adult NSF, prospective14–19 | 277 | 44 | 442 | 1.1 |
Adult NSF, retrospective13,20–24 | 177 | 54 | 312 | 1.1 |
Adolescents NSF, retrospective25 | 10 | 41.8 | 646 | 1.49 |
Primarily stone formers, any type26–28 | 166 | 71 | 415 | 1.4 |
LAGB or SG 24-h urine (∼12 months F/U) | ||||
Adult NSF, retrospective21,22 | 30 | 36 | NR | 1.3 |
Adolescents NSF, retrospective25 | 7 | 26.4 | 687 | 0.95 |